Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer
Miguel García-Pardo(Hospital Universitario Ramón y Cajal), Natasha B. Leighl(Princess Margaret Cancer Centre), Lucy Corke(University Health Network), Thomas K. Waddell(University Health Network), Christodoulos Pipinikas, Noor Ghumman(University Health Network), Bana Ambasager, Kasia Czarnecka‐Kujawa(University Health Network), Laura Donahoe(University Health Network), Adrian G. Sacher(Princess Margaret Cancer Centre), Tracy Stockley(University Health Network), Kazuhiro Yasufuku(University Health Network), Jamie Feng(University Health Network), Alexandra Salvarrey(University Health Network), Patrik Rogalla(Charité - Universitätsmedizin Berlin), Lisa W. Le(University Health Network), Ming‐Sound Tsao(Kumamoto University), Karen Howarth(Granta Design (United Kingdom)), Frances A. Shepherd(University Health Network), Sabine Schmid(University of Bern), Tharsiga Gunasegaran(University Health Network), Geoffrey Liu(Princess Margaret Cancer Centre), Andrew Pierre(University Health Network), Jennifer Law(University Health Network), Penelope A. Bradbury(University Health Network), Zhen Jason Fan(University Health Network), Prodipto Pal(University Health Network), Roxanne Fernandes(University Health Network), Laura Mezquita(Hospital Clínic de Barcelona)
Cited by 60
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k